Q&A: Verily on using generative AI within healthcare

The article discusses Alphabet’s life science subsidiary, Verily, and its strategic shift towards using AI and data science to enhance precision health solutions. Andrew Trister, Verily’s chief medical and science officer, elaborates on the company’s use of AI, collaborations with Google, and the future prospects of the business. Here are three key highlights from the article:

1. Verily’s Evolution: Verily, which emerged from Google X in 2015, has been actively involved in various healthcare areas such as research, device development, disease measurement, care delivery, and care financing. The company aims to leverage better measurements, data insights, and actions to improve healthcare outcomes.

2. Collaboration with Google in AI: Verily collaborates with Google on projects that integrate AI technology into healthcare solutions. For instance, the development of an automated retinal camera by Verily enables the capture of back-of-eye images for diagnostic purposes using Google’s AI. Such partnerships aim to bring meaningful impact to healthcare practices.

Editorial content by NewsSIP AI